Redefining Life Sciences Industry in India

A combination of demographic, regulatory and technological changes coupled with the current global scenario has created an inflection point for the Life Sciences industry in India.

With a record 140 million households likely to enter the middle class over the next few years merged with the governments thrust on universal healthcare through Ayushman Bharat and focus on local manufacturing via Atmanirbhar Bharat, the Life Sciences industry is expected to grow exponentially. The focus will be on new drug discovery, designing, engineering and manufacturing efficient medical devices, to providing new and enhanced patient experiences while adhering to low-costs and a rigid policy framework.

Indian pharma sector is projected to grow to US$ 100 billion by 2025, while the medical device market expected to touch US$ 25 billion within the same period. This when combined with government-led initiatives like 100% FDI for manufacturing of medical devices in India and the ‘Pharma Vision 2020’ document aimed at making India a global leader in end-to-end drug manufacture, makes the Life Sciences industry a highly lucrative segment.

In addition to drug discovery and medical device manufacturing, another area poised to take off is telemedicine with the National Health Stack (NHS); a virtual digital platform that will centralize all digital health records for Indian citizens by 2022 to make telemedicine and e-Health effortless.

In such a scenario, both life sciences and health personnel have become an integral part of our ecosystem, and the industry presents massive opportunities for all three sub-segments in the post-pandemic era.

Acing innovation in the industry

The World After: From Things to Life 2020 is a one-of-its-kind virtual conference that will provide in-depth insights into the vast potential of the Life Sciences sector in India. The event will cover numerous facets of the industry and provide insights into optimizing them to achieve complete transformation and meet diverse and elastic market demand.

The three essential sub-segments that the event will address are

Medical device manufacturers – design, discovery, engineering to manufacturing
Pharma & Biotech – rapid research on new molecules and drug discovery while adhering to regulatory compliance
Patient Care: targeted solutions for personalized healthcare and improved patient outcomes

Addressing the business challenges of life science Industry, Dassault Systemes, will be demonstrating License to Cure for bio-pharma, ONE Lab, Collaborative Scientific Innovation, Accelerated Cure for Medical Devices Industry Solution Experiences based on the 3DEXPERIENCE platform.

Visionary speakers will address the event

Redefining the Life Sciences industry in India in the plenary session
- Our key note speaker- Kiran Mazumdar-Shaw, Executive Chairperson, Biocon will provide a perspective into the challenges and opportunities of the Indian pharmaceutical industry
- We will also have our honourable guest speaker, H. E. Emmanuel LENAIN, Ambassador of France to India, address the audience
- Renuka Srinivasan, Life Sciences industry lead, India, Dassault Systemes will moderate a session with Claire Biot, VP, Life Sciences industry, Dassault Systemes on virtual universes for modeling & simulation
- Samson Khaou, Executive Vice President, Asia, Dassault Systemes & Deepak NG, Managing Director, India, Dassault Systemes will pave the way for the shift in strategy- ‘From Things to Life’
Pharma and bio-pharma
- Askok Nayak, CIO, IPCA Laboratories will showcase digital transformation in the pharma sector in the plenary session
- The pharma track has an interesting line up of topics
  - An opportunity for digital continuity in pharmaceutical industry- John Mccarthy, Senior Director, Business Strategy, Life Science Industry, Dassault Systemes
  - LEADS – Lupin’s Electronic Document Management System implementation- Rahul Borse, Sr. Manager (QAIT), CSV, Lupin
  - Revolutionizing the drug development process with artificial intelligence- Dr. Anand Krishnamurthy, Industry Process Consultant Senior Manager, BIOVIA, Dassault Systemes
  - Drug Design and Development Against Novel Coronavirus – Dr (Prof.) Md. Imtaiyaz Hassan, Assistant Professor, Jamia Milia Islamia University
  - Optimize your laboratories and leverage knowledge to improve time to market- Sunil Dubey, Industry Process Consultant Manager, BIOVIA, Dassault Systemes
Patient care and simulation technologies
- Arun Rao, Senior Director, Customer Process Experience, India, Dassault Systemes will moderate a session on accelerated adoption of simulation in life sciences with Dr. Ramanan
  Lakshminarayanan, Chief Technology Officer, Sahajanand Medical Technologies (SMT)
- In the track
  - In-Silico in healthcare : The way forward- Dwarak Krishnan, Industry Process Consultant, Dassault Systemes
  - Adoption of Simulation in Medical Device Applications- Dr. Venkat Perumal, Senior Principal Engineer, Stryker
  - Simulation driven new product development (NPD)- Sivakumar Anbazhagan, Senior Project Manager, CAE, Product Development, HCL Technologies
  - Simulation for understanding the functional dynamics of the brain and therapeutic stimulations using AI- Dr. Rimjhim Agrawal, Co-founder, and CTO of BrainSight Technology

Medical devices design engineering and manufacturing
- In the plenary, PM Ravikumar, Management Director, Customer Role Experience, India, Dassault Systemes and Ramakrishnan Venkataraman, South Sales Director, Customer Role Experience, India, Dassault Systemes will moderate a session on transforming medical devices with sustainable digital innovation with Vishwaprasad Alva, Managing Director, Skanray
- In the medical devices track
  - Bringing innovative medical devices to market faster- Gurpreet Singh, Industry Consultant Senior Manager – 3DEXPERIENCE WORKS, Dassault Systemes & Fakkirappa Hottinavar, Industry Consultant Manager – Simulation products, 3DEXPERIENCE WORKS, Dassault Systemes
  - Technology solutions adopted in diagnostics industry- Varghese N Ouseph, Associate Vice President, Agappe Diagnostics
  - A journey of Medical Devices Start-up- Satish Kalme, Chief Executive Officer and Co-Founder, COMOFI Medtech
  - Accelerate innovation with shorter design and validation cycles with reduce time–to–market and engineering costs- Gurpreet Singh, Industry Consultant Senior Manager, 3DEXPERIENCE WORKS, Dassault Systemes

Alongside these sessions the event features dedicated industry segment tracks led by brands like BIOVIA, SOLIDWORKS and SIMULIA. The 3DEXPERIENCE playground will showcases innovations on these brands and virtual experiences of technology demos of internet of things, artificial intelligence, machine leaning & data analytics applicable in the life sciences industry.